Canaccord Genuity are Buyers of AngioDynamics (ANGO) on Weakness

April 10, 2015 9:55 AM

Canaccord Genuity analyst Jason Mills lowered his price target on AngioDynamics (NASDAQ: ANGO) to $20.00 (from $22.00) following soft Q3 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found